Effects of levosimendan on myocardial ischaemia-reperfusion injury

被引:19
|
作者
Yapic, D. [1 ]
Altunkan, Z. [1 ]
Ozerent, M. [2 ]
Bilgln, E. [1 ]
Balli, E. [3 ]
Tamer, L. [4 ]
Doruk, N. [1 ]
Birbicer, H. [1 ]
Apa, D. [5 ]
Oral, U. [1 ]
机构
[1] Mersin Univ, Fac Med, Dept Anaesthesiol & Intens Care, TR-33079 Zeytinlibahce C, Mersin, Turkey
[2] Mersin Univ, Fac Med, Dept Cardiovasc Surg, TR-33079 Zeytinlibahce C, Mersin, Turkey
[3] Mersin Univ, Fac Med, Dept Histol, TR-33079 Zeytinlibahce C, Mersin, Turkey
[4] Mersin Univ, Fac Med, Dept Biochem, TR-33079 Zeytinlibahce C, Mersin, Turkey
[5] Mersin Univ, Fac Med, Dept Pathol, TR-33079 Zeytinlibahce C, Mersin, Turkey
关键词
heart; drug; levosimendan; ischemic preconditioning; hypothermic; cardioplegic; rat;
D O I
10.1017/S0265021507002736
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and objective: Levosimendan has a cardioprotective action by inducing coronary vasodilatation and preconditioning by opening K(ATP), channels. The aim of this study was to determine whether levosimendan enhances myocardial damage during hypothermic ischaemia and reperfusion in isolated rat hearts. Methods: Twenty-one male Wistar rats were divided into three groups. After surgical preparation, coronary circulation was started by retrograde aortic perfusion using Krebs-Henseleit buffer solution and lasted 15 min. After perfusion Group 1 (control; n = 7) received no further treatment. In Group 2 (non-treated; n = 7), hearts were arrested with cold cardioplegic solution after perfusion and subjected to 60 min of hypothermic global ischaemia followed by 30 min reperfusion. In Group 3 (levosimendan treated; n = 7), levosimendan was added to the buffer solution during perfusion and the hearts were arrested with cold cardioplegic solution and subjected to 60 min of hypothermic global ischaemia followed by 30 min reperfusion. At the end of the reperfusion period, the hearts were prepared for biochemical assays and for histological analysis. Results: Tissue malondialdehyde levels were significantly lower in the levosimendan-treated group than in the non-treated group (P = 0.019). The tissue Na -K(+) ATPase activity was significantly decreased in the non-treated group than in the levosimendan-treated group (P = 0.027). Tissue myeloperoxidase (MPO) enzyme activity was significantly higher in the non-treated group than in the levosimendan-treated group (P = 0.004). Electron microscopic examination of the hearts showed cardiomyocytic degeneration at the myofibril, mitochondria and sarcoplasmic reticulum in both non-treated and levosimendan-treated groups. The severity of these findings was more extensive in the non-treated group. Conclusions: Treatment with levosimendan provided better cardioprotection with cold cardioplegic arrest followed by global hypothermic ischaemia in isolated rat hearts.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 50 条
  • [1] Effect of levosimendan on erythrocyte deformability during myocardial ischaemia-reperfusion injury
    Arslan, M.
    Comu, F. M.
    Alkan, M.
    Kiraz, H. A.
    Kip, G.
    Ozer, A.
    Sivgin, V
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2015, 116 (01): : 47 - 50
  • [2] Efect of Levosimendan and Nigella Sativa on Erythrocyte Deformability During Myocardial Ischaemia-Reperfusion Injury in Rats
    Ozer, Abdullah
    Comu, Faruk Metin
    Kucuk, Aysegul
    Kilic, Yigit
    Mardin, Baris
    Alkan, Metin
    Oktar, Gursel Levent
    Unal, Yusuf
    Arslan, Mustafa
    ACTA PHYSIOLOGICA, 2017, 221 : 45 - 46
  • [3] Effect of Levosimendan and Nigella Sativa on Erythrocyte Deformability During Myocardial Ischaemia-Reperfusion Injury in Rats
    Ozer, Abdullah
    Comu, Faruk Metin
    Kucuk, Aysegul
    Kilic, Yigit
    Mardin, Baris
    Alkan, Metin
    Oktar, Levent
    Arslan, Mustafa
    Unal, Yusuf
    GAZI MEDICAL JOURNAL, 2018, 29 (02): : 113 - 115
  • [4] Myocardial ischaemia-reperfusion injury and cardioprotection in perspective
    Heusch, Gerd
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (12) : 773 - 789
  • [5] Stabilizing Microtubules Decreases Myocardial Ischaemia-Reperfusion Injury
    Cao, H-M
    Wang, Q.
    You, H-Y
    Li, J.
    Yang, Z-Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 1713 - 1719
  • [6] The role of the neuropeptide y in myocardial ischaemia-reperfusion injury
    Alshehri, A. S.
    Baxter, G. F.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S70 - S70
  • [7] Investigation into the role of mavacamten in myocardial ischaemia-reperfusion injury
    Yusof, Liyana
    Yellon, Derek
    Davidson, Sean
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S2 - S2
  • [8] Extracellular histones are a target in myocardial ischaemia-reperfusion injury
    Shah, Mohammed
    He, Zhenhe
    Rauf, Ali
    Kalkhoran, Siavash B.
    Heiestad, Christina Mathisen
    Stenslokken, Kare-Olav
    Parish, Christopher R.
    Soehnlein, Oliver
    Arjun, Sapna
    Davidson, Sean M.
    Yellon, Derek
    CARDIOVASCULAR RESEARCH, 2022, 118 (04) : 1115 - 1125
  • [9] Morphine and myocardial ischaemia-reperfusion
    Wu, Li-Ning
    Hu, Rui
    Yu, Jun-Ma
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 891
  • [10] Effects of sufentanil postconditioning on myocardial ischaemia-reperfusion injury in diabetic rats in vivo
    Chen, Q. L.
    Gu, E. W.
    Cao, Y. Y.
    Zhang, L.
    BRITISH JOURNAL OF ANAESTHESIA, 2012, 108 (03) : 547 - 548